1. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study. (May 2017) Authors: Razavi, Homie; Robbins, Sarah; Zeuzem, Stefan; Negro, Francesco; Buti, Maria; Duberg, Ann-Sofi; Roudot-Thoraval, Françoise; Craxi, Antonio; Manns, Michael; Marinho, Rui T; Hunyady, Bela; Colombo, Massimo; Aleman, Soo; Antonov, Krasimir; Arkkila, Perttu; Athanasakis, Kostas; Blach, Sarah; Blachier... Journal: Lancet gastroenterology and hepatology Issue: Volume 2:Number 5(2017) Page Start: 325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Incidence of hepatitis C among people who inject drugs in Ireland. Issue 1 (December 2016) Authors: Carew, Anne; Murphy, Niamh; Long, Jean; Hunter, Kate; Lyons, Suzi; Walsh, Cathal; Thornton, Lelia Journal: Hepatology, medicine and policy Issue: Volume 2:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. Issue 7253 (8th July 2000) Authors: Allwright, Shane; Bradley, Fiona; Long, Jean; Barry, Joseph; Thornton, Lelia; Parry, John V Journal: BMJ Issue: Volume 321:Issue 7253(2000) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗